Investing.com -- Oggi, la Food and Drug Administration (FDA) statunitense ha approvato Journavx (suzetrigine) 50 milligrammi in compresse orali di Vertex Pharmaceuticals (NASDAQ: VRTX). Questo nuovo f ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback